Pazopanib shows positive results in phase II trials

Pazopanib, another anti-angiogenesis drug, has shown positive results in Phase II trials for advanced kidney cancer.

For more information about pazopanib, see:

http://www.medicalnewstoday.com/articles/73025.php

Leave a Reply

Your email address will not be published. Required fields are marked *

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.
This site is registered on Toolset.com as a development site.